Consensus CONMED Corporation

Stocks

CNMD

US2074101013

Medical Equipment, Supplies & Distribution

Market Closed - NYSE 04:00:03 2026-09-04 pm EDT			5-day change	1st Jan Change
49.32 ^USD	-0.20%		-1.32%	+21.48%

Jul. 30	CONMED Q2 Adjusted Earnings, Revenue Rise; 2026 Guidance Raised	MT
Jul. 30	CONMED Corporation, Q2 2026 Earnings Call, Jul 29, 2026

Evolution of the Average Target: CONMED Corporation

Evolution of the Target Price: CONMED Corporation

Changes in Analyst Recommendations: CONMED Corporation

a8329.RJFeSjHabjJ1yWDlKpVDxAZiW0oElZtGa7lpBcAN1Uo.L90uBH-VF0gRig3IRt0uinNWMzJy89EMCP0RZ7Vquy0TxhcrAOkqexGvKQ~872548549853e04fca6c6a6a8cb281e7

Analysts' recommendations: CONMED Corporation

Jul. 09	BMO Capital Initiates CONMED at Market Perform With $36 Price Target	MT
Jun. 29	CONMED Lagging Medtech Peers as Growth Slows, BofA Securities Says	MT
Jun. 29	BofA Downgrades CONMED to Underperform From Neutral, Keeps $40 Price Target	MT
May. 18	BofA Securities Adjusts CONMED Price Target to $40 From $52	MT
Mar. 17	Piper Sandler Downgrades CONMED to Neutral From Overweight, Adjusts PT to $39 From $55	MT
25-06-12	Conmed Shares Fall After Needham Downgrade	MT
25-06-12	Needham Downgrades CONMED to Hold From Buy, Removes $61 Price Target	MT
25-04-28	Stifel Downgrades CONMED to Hold From Buy, Adjusts Price Target to $55 From $75	MT
25-02-06	JPMorgan Downgrades CONMED to Neutral From Overweight, Adjusts Price Target to $70 From $85	MT
24-08-01	Needham Adjusts CONMED's Price Target to $97 From $106, Keeps Buy Rating	MT
24-07-25	Needham Trims Price Target on CONMED to $106 From $107, Keeps Buy Rating	MT
24-04-25	Wells Fargo Adjusts Price Target on CONMED to $77 From $98, Maintains Equalweight Rating	MT
24-04-25	Needham Lowers Price Target on CONMED to $107 From $129, Notes Slight Guidance Cut Due to Currency, Keeps Buy Rating	MT
24-02-01	Needham Adjusts Price Target on CONMED to $129 From $119, Maintains Buy Rating	MT
24-02-01	JPMorgan Cuts CONMED Price Target to $115 From $135, Maintains Overweight Rating	MT
23-10-27	Piper Sandler Adjusts Price Target on CONMED to $130 From $145, Maintains Overweight Rating	MT
23-10-26	Wells Fargo Cuts Price Target on CONMED to $107 From $123, Maintains Equalweight Rating	MT
23-07-27	Needham Adjusts Price Target on CONMED to $140 From $139, Maintains Buy Rating	MT
23-07-27	Keybanc Adjusts Price Target on CONMED to $141 From $131, Maintains Overweight Rating	MT
23-06-05	Needham Raises Price Target on CONMED to $139 From $135, Keeps Buy Rating	MT
23-05-22	CL King Starts CONMED at Buy With $140 Price Target	MT
23-04-27	Piper Sandler Raises CONMED's Price Target to $128 From $118, Maintains Overweight Rating	MT
23-04-27	Wells Fargo Adjusts Price Target on CONMED to $119 From $96, Maintains Equal-Weight Rating	MT
23-04-27	Needham Adjusts Price Target on CONMED to $135 From $122, Reiterates Buy Rating	MT
23-04-27	Keybanc Adjusts Price Target on CONMED to $131 From $124, Maintains Overweight Rating	MT

More recommendations

Other Medical Equipment, Supplies & Distribution

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	CONMED CORPORATION					-7.75%
	ABBOTT LABORATORIES					+10.96%
	MEDTRONIC PLC					+11.25%
	CENCORA, INC.					+11.59%
	HOYA CORPORATION					+27.04%
	BECTON, DICKINSON AND COMPANY					+5.91%
	DEXCOM, INC.					+7.08%
	MEDLINE INC.					+21.89%
	WEST PHARMACEUTICAL SERVICES, INC.					+19.05%
	TERUMO CORPORATION					+29.14%
	Average					+13.62%
	Weighted average by Cap.					+13.44%